ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,909.03
      -1.11%
      US Tech 100
      20,607.20
      0.00%
      Dow Jones
      42,528.36
      -0.42%
      Brent Oil
      77.615
      0.72%
      Bitcoin
      95,971.74
      -0.96%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. SciSparc Ltd (SPRC)

      7. SciSparc Ltd (SPRC) News

      SPRC

      SciSparc (SPRC)

      SciSparc Ltd
      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:SPRC
      DateTimeSourceHeadlineSymbolCompany
      1:35PMiHub NewswireFeaturedEzFill Holdings, Inc. Successfully Closes Acquisition of Shell Fleet, Accelerating Nationwide Mobile Fueling Expansion
      01/07/20257:25AMGlobeNewswire Inc.SciSparc: MitoCareX Bio Expands Research to Pancreatic Cancer Following Initial In-Vitro Positive ResultsNASDAQ:SPRCSciSparc Ltd
      01/07/20256:15AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SPRCSciSparc Ltd
      01/06/20257:50AMGlobeNewswire Inc.SciSparc-Clearmind Medicine Collaboration Announces the Publication of European Patent Application for Binge Behavior Psychedelic Combination TreatmentNASDAQ:SPRCSciSparc Ltd
      12/31/20244:16PMEdgar (US Regulatory)Form F-4/A - Registration of securities, foreign private issuers, business combinations: [Amend]NASDAQ:SPRCSciSparc Ltd
      12/31/20244:01PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SPRCSciSparc Ltd
      12/31/20249:24AMGlobeNewswire Inc.SciSparc Announces Renewal of Approval by Israeli Medical Cannabis Agency for its Clinical Trial in Children with Autism Spectrum DisorderNASDAQ:SPRCSciSparc Ltd
      12/26/20244:06PMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:SPRCSciSparc Ltd
      12/26/20244:04PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SPRCSciSparc Ltd
      12/26/20246:46AMGlobeNewswire Inc.SciSparc: AutoMax Announces $13 Million First Delivery of JAC Vehicles Following Regulatory Approval for Direct ImportationNASDAQ:SPRCSciSparc Ltd
      12/17/20247:53AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SPRCSciSparc Ltd
      12/16/20247:40AMGlobeNewswire Inc.SciSparc Provides Updates on Status of Spin-off of its Advanced Clinical Stage Pharmaceutical Portfolio to a Publicly Traded CompanyNASDAQ:SPRCSciSparc Ltd
      11/29/20248:56AMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:SPRCSciSparc Ltd
      11/29/20248:51AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SPRCSciSparc Ltd
      11/27/20244:53PMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:SPRCSciSparc Ltd
      11/27/20244:50PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SPRCSciSparc Ltd
      11/04/20244:00PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SPRCSciSparc Ltd
      10/23/20248:51AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SPRCSciSparc Ltd
      10/22/20244:00PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SPRCSciSparc Ltd
      09/30/20249:25AMGlobeNewswire Inc.SciSparc Secures FDA Green Light to US Launch of its Pivotal Phase IIb Clinical Trial for Breakthrough Tourette Syndrome TreatmentNASDAQ:SPRCSciSparc Ltd
      09/27/20244:01PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SPRCSciSparc Ltd
      09/26/20249:21AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SPRCSciSparc Ltd
      09/26/20249:05AMGlobeNewswire Inc.SciSparc Signs Non-Binding Letter of Intent to Sell Stake in MitoCareXNASDAQ:SPRCSciSparc Ltd
      09/23/20249:10AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SPRCSciSparc Ltd
      09/23/20248:17AMGlobeNewswire Inc.SciSparc Receives FDA Approval to Initiate Phase IIb Clinical Trial for Tourette Syndrome TreatmentNASDAQ:SPRCSciSparc Ltd
      09/18/20244:09PMGlobeNewswire Inc.SciSparc Takes Major Step Forward with IND Application submitted to the FDA for Phase IIb Clinical Trial for Tourette Syndrome TreatmentNASDAQ:SPRCSciSparc Ltd
      09/16/20244:15PMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SPRCSciSparc Ltd
      09/16/20244:06PMGlobeNewswire Inc.SciSparc-Clearmind Medicine Collaboration Announces the Publication of an International Patent Application for Pioneering Ibogaine Combination TherapyNASDAQ:SPRCSciSparc Ltd
      09/11/20249:26AMEdgar (US Regulatory)Form 425 - Prospectuses and communications, business combinationsNASDAQ:SPRCSciSparc Ltd
      09/11/20249:24AMEdgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SPRCSciSparc Ltd
       Showing the most relevant articles for your search:NASDAQ:SPRC